Religiosity and the Spread of COVID-19: A Multinational Comparison.

This article considers the relationships between population religiosity and the coronavirus pandemic situation across different countries. Country-level analyses were based on data from the World Values Survey, Worldometer, and International Monetary Fund covering information about internal (beliefs) and external (practices) religiosity, religious fundamentalism, the COVID-19 pandemic, and the economic situation at two time points in 47 countries. Results showed that declared attendance at religious services is related to more COVID-19 infections and deaths, as well as when controlling for gross domestic product per capita and the number of coronavirus tests per 1 million population.

Chronotype in individuals with schizophrenia: A meta-analysis.

Objective: Emerging evidence shows that evening chronotype is associated with mental health problems, especially mood disorders, but few studies have investigated its association with schizophrenia. Based on meta-analytic methods, we aimed to test whether eveningness is greater in individuals with schizophrenia compared with healthy controls and patients with bipolar I disorder.

Method: Medline/Pubmed, Google Scholar, and EBSCO databases were searched up to April 2021 for articles investigating chronotype in individuals with schizophrenia.

Angry night birds: Emotionality, activity and sociability temperament in adolescent chronotypes.

There is growing interest in personality profiles associated with morningness-eveningness to foster an understanding of the behaviors and mental states of chronotypes. This study aimed to analyze the domains of emotionality, activity and sociability (EAS) temperament in relation to morningness-eveningness in adolescents. A sample of 539 school pupils aged 13-19 years completed the EAS Temperament Survey, the Composite Scale of Morningness and the Munich Chronotype Questionnaire.

Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients.

Computerised cognitive remediation therapy (CCRT) has been shown to improve cognitive function in individuals with schizophrenia beyond effects of other forms of therapy. However, results vary between studies, and most are aimed at individuals who are living in the community. Very few studies have investigated its efficacy in psychiatric wards in order to assess whether or not this is a suitable site to start the therapy.

Polish Version of the Managing the Emotions of Others Scale (MEOS): Psychometric Properties and Validation.

The present study aimed to test the psychometric properties of the Polish version of the managing the emotions of others scale (MEOS). MEOS consists of six dimensions: mood enhancing (Enhance), mood worsening (Worsen), concealing emotions from others (Conceal), use of inauthentic displays for self-serving purposes (Inauthentic), poor emotion skills (Poor skills), and use of diversion to enhance another's mood (Divert). The results showed that among MEOS dimensions, Enhance was the most strongly related to performance-based emotional intelligence.

[The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report].

Aim: The assessment of cognitive impairment in schizophrenia proves helpful in the diagnosis of disease, identification of individuals at risk for adverse outcome and choosing the most adequate treatment. It is also a valuable complement of the psychiatric diagnosis. For this reason, there is a great need for a practical well-validated instrument to measure cognitive deficits that can be administered and interpreted easily in a clinical setting.

[Cognitive rehabilitation for people living with schizophrenia - the newest interventions].

The article reviews the latest interventions in cognitive rehabilitation for patients with schizophrenia. Studies referring to cognitive rehabilitation for people with schizophrenia from the last three years, found in the PubMed database, are presented. The authors categorised cognitive rehabilitation trainings in terms of targeted cognitive spheres - neurocognitive training, social cognition training, emotion perception training and combined training - and present current trends within this approaches.

The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.

Work and social functioning in schizophrenia are strongly influenced by cognitive impairment so improving cognition is a priority in the treatment of schizophrenia. Until recently the lack of a widely accepted index of cognitive change for use in schizophrenia was a major obstacle to the development of cognition enhancing treatments. The MATRICS (measurement and treatment research to improve cognition in schizophrenia) consensus cognitive battery (MCCB) was developed as a standard cognitive battery for use in clinical trials of cognition enhancing treatments for schizophrenia and has attracted worldwide interest.

Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?

In schizophrenia patients, both an older age and earlier age at onset of the disease are related to worse cognitive functioning. As patients with later schizophrenia onset are also older, analysing the two effects separately can be misleading, as they can either be spurious or cancel one another out. The purpose of the present study was to elucidate the effects of age and onset-age on cognition in schizophrenia patients.

Electroencephalographic theta activity and cognition in schizophrenia: preliminary results.

Objectives: MATRICS Consensus Cognitive Battery (MCCB) is a contemporary standard for assessment of cognitive functions in schizophrenia. The aim of the study was to examine the association between electroencephalographic spectral power and a wide range of cognitive functions measured with MCCB.

Methods: Thirty-nine patients with schizophrenia (27 male, mean age 28.

[MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].

Cognitive dysfunctions often occur long before the onset of psychotic symptoms of schizophrenia. They include mostly deficits in attention, memory (including working memory) and executive functions. The level of cognitive impairment strongly influences the subjective quality of life and the ability to perform in social and professional roles.